Activin and Inhibin

GSK-J1 lithium salt is a potent inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A , with IC 50 of 60 nM towards KDM6B.Appearance:SolidIC50&amp: Target:IC50: 60 nM (KDM6B)In Vitro:GSK-J1 is selective for H3K27 demethylases of the KDM6

GSK-J1 lithium salt is a potent inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A , with IC 50 of 60 nM towards KDM6B.Appearance:SolidIC50&amp: Target:IC50: 60 nM (KDM6B)In Vitro:GSK-J1 is selective for H3K27 demethylases of the KDM6

GSK1059865 is a potent orexin 1 receptor antagonist.In VivoTreatment with GSK1059865 significantly decreases ethanol drinking in a dose-dependent manner in CIE-exposed mice. In contrast GSK1059865 decreases drinking in air-exposed mice only at the

GSK1059865 is a potent orexin 1 receptor antagonist.In VivoTreatment with GSK1059865 significantly decreases ethanol drinking in a dose-dependent manner in CIE-exposed mice. In contrast GSK1059865 decreases drinking in air-exposed mice only at the

GSK1059865 is a potent orexin 1 receptor antagonist.In VivoTreatment with GSK1059865 significantly decreases ethanol drinking in a dose-dependent manner in CIE-exposed mice. In contrast GSK1059865 decreases drinking in air-exposed mice only at the

GSK1059865 is a potent orexin 1 receptor antagonist.In VivoTreatment with GSK1059865 significantly decreases ethanol drinking in a dose-dependent manner in CIE-exposed mice. In contrast GSK1059865 decreases drinking in air-exposed mice only at the

GSK1059865 is a potent orexin 1 receptor antagonist.In VivoTreatment with GSK1059865 significantly decreases ethanol drinking in a dose-dependent manner in CIE-exposed mice. In contrast GSK1059865 decreases drinking in air-exposed mice only at the

GSK1059865 is a potent orexin 1 receptor antagonist.In VivoTreatment with GSK1059865 significantly decreases ethanol drinking in a dose-dependent manner in CIE-exposed mice. In contrast GSK1059865 decreases drinking in air-exposed mice only at the

GSK1059865 is a potent orexin 1 receptor antagonist.In VivoTreatment with GSK1059865 significantly decreases ethanol drinking in a dose-dependent manner in CIE-exposed mice. In contrast GSK1059865 decreases drinking in air-exposed mice only at the

GSK1521498 free base is a potent and selective μ-opioid receptor (MOR) antagonist. GSK1521498 free base has the potential for disorders of compulsive consumption of food, alcohol, and agentsForm:SolidIC50&amp: Target:μ Opioid Receptor/MOR.

GSK1521498 free base is a potent and selective μ-opioid receptor (MOR) antagonist. GSK1521498 free base has the potential for disorders of compulsive consumption of food, alcohol, and agentsForm:SolidIC50&amp: Target:μ Opioid Receptor/MOR.

GSK1521498 free base is a potent and selective μ-opioid receptor (MOR) antagonist. GSK1521498 free base has the potential for disorders of compulsive consumption of food, alcohol, and agentsIC50&amp: Target:μ Opioid Receptor/MOR.